لا تُقدم XM خدماتها لمواطني الولايات المتحدة الأمريكية.
G
G

Getinge


أخبار

FDA Identified Getinge's Recall Of Vaporizer Sevoflurane Maquet Filling As Class I Recall

BRIEF-FDA Identified Getinge's Recall Of Vaporizer Sevoflurane Maquet Filling As Class I Recall June 13 (Reuters) - Getinge AB GETIb.ST : FDA:GETINGE RECALLS VAPORIZER SEVOFLURANE MAQUET FILLING FOR RISK OF PATIENT AND HEALTH CARE PROFESSIONAL EXPOSURE TO TOXIC CHEMICAL HYDROGEN FLUORIDE FDA: IDENTIFIED GETINGE'S RECALL OF VAPORIZER SEVOFLURANE MAQ
G

Getinge Granted U.S. FDA 510(K) Clearance For Its Innovative Clinical Decision Support Software Talis +Acg

BRIEF-Getinge Granted U.S. FDA 510(K) Clearance For Its Innovative Clinical Decision Support Software Talis +Acg June 12 (Reuters) - Getinge AB GETIb.ST : GETINGE: GRANTED U.S. FDA 510(K) CLEARANCE FOR ITS INNOVATIVE CLINICAL DECISION SUPPORT SOFTWARE TALIS +ACG Source text for Eikon: [ID:] Further company coverage: [GETIb.ST]
G

Getinge Sees Acute Care Therapies 2024-2028 Net Sales Organic Growth Of 3-5%

BRIEF-Getinge Sees Acute Care Therapies 2024-2028 Net Sales Organic Growth Of 3-5% May 15 (Reuters) - Getinge AB GETIb.ST : GETINGE CEO ON ACUTE CARE THERAPIES UNIT: PROJECTS ORGANIC GROWTH IN NET SALES OF 3-5% IN 2024-2028 GETINGE CEO ON LIFE SCIENCE UNIT: PROJECTS ORGANIC GROWTH IN NET SALES OF 6-10% IN 2024-2028 GETINGE CEO ON SURGICAL WORKFLOWS
G

Getinge heart device quality issues weigh as co issues new outlook target

BUZZ-Getinge heart device quality issues weigh as co issues new outlook target ** Shares in Getinge GETIb.ST fall 8% after the medical equipment maker issues new midterm guidance , but says finances will continue to be negatively impacted by ongoing quality issues with its heart devices until new products are launched ** The company said it targets over 12% growth on average in its adjusted EPS for 2024-2028, compared to its previous target for over 10% growth in EPS for 2022-2025 ** "New mid-te
G
J

Getinge limits sale of heart devices in the US after FDA warning

Getinge limits sale of heart devices in the US after FDA warning May 15 (Reuters) - Sweden's Getinge GETIb.ST will limit sales of some of its heart products in the U.S., the medical equipment maker said late on Tuesday, after recent advice from the U.S. Food and Drug Administration (FDA) to move away from its devices. "We have decided to immediately pause promotional activities of the Cardiohelp System and Cardiosave Intra-Aortic Balloon Pump in the U.S.
G

Getinge Says Financial Target 2024-2028 Is Adjusted EPS Growth Of Above 12% On Average

BRIEF-Getinge Says Financial Target 2024-2028 Is Adjusted EPS Growth Of Above 12% On Average May 14 (Reuters) - Getinge AB GETIb.ST : GETINGE'S FINANCIAL TARGET 2024-2028: ADJUSTED EPS GROWTH OF ABOVE 12% ON AVERAGE FOR 2024, GETINGE REPEATS ITS GUIDANCE OF 2-5% ORGANIC GROWTH IN NET SALES AND 3-5% GROWTH FROM ACQUIRED UNITS DOES NOT PROVIDE ANY AN
G

Medical gear maker Getinge falls after FDA issues safety warning

BUZZ-Medical gear maker Getinge falls after FDA issues safety warning Adds company comment in 3rd bullet, updates shares ** Shares in Getinge GETIb.ST drop about 7% after U.S. FDA issued a warning on the safety of two of the Swedish medical equipment maker's heart devices ** FDA advised healthcare facilities to switch from Getinge's heart devices amid safety concerns ** " We take this very seriously and have an ongoing dialogue with the FDA on how to best address this," says Elin Frostehav, Pres
G
S

STOXX 600 closes at record high on earnings, rate cut optimism

UPDATE 2-STOXX 600 closes at record high on earnings, rate cut optimism For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Rio Tinto considered bid for BHP-target Anglo American -report Green energy production in Italy boosts Enel's Q1 results Medical gear maker Getinge plummets after FDA's safety warning Italy industry output posts unexpected fall in March Updated at 1552 GMT By Ankika Biswas and Johann M Cherian May 10 (Reuters) - Europe
E
G
R
S
S
Z
A
R
E
F
G

New records for STOXX 600, FTSE 100 and DAX; CAC closing in on fresh peak

LIVE MARKETS-New records for STOXX 600, FTSE 100 and DAX; CAC closing in on fresh peak STOXX 600 up 0.6% to new peak DAX and FTSE also at records Wall St futures inch up Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com NEW RECORDS FOR STOXX 600, FTSE 100 AND DAX; CAC CLOSING IN ON FRESH PEAK The pan-European benchmark STOXX 600 .STOXX hit a new intraday record on Friday and is hea
G
E
F
U
G

Medical gear maker Getinge plummets after FDA issues safety warning

BUZZ-Medical gear maker Getinge plummets after FDA issues safety warning ** Shares in Getinge GETIb.ST drop about 8% after U.S. FDA issued a warning on the safety of two of the Swedish medical equipment maker's heart devices ** FDA advised healthcare facilities to switch from Getinge's heart devices amid safety concerns ** Getting did not immediately reply to an emailed request for comment and could not be reached for comment by phone ** Kepler Cheuvreux, via Swedbank Aktiellt, says that while n
G
S

US FDA advises healthcare facilities to switch from Getinge's heart devices

UPDATE 2-US FDA advises healthcare facilities to switch from Getinge's heart devices Adds details in paragraphs 5 & 6, background throughout May 8 (Reuters) - The U.S Food and Drug Administration (FDA) on Wednesday advised healthcare facilities to move away from using Getinge's GETIb.ST heart devices in patients as they faced safety and quality concerns despite a string of recalls.
G

US FDA recommends healthcare providers switch from Getinge's heart devices

US FDA recommends healthcare providers switch from Getinge's heart devices May 8 (Reuters) - The U.S Food and Drug Administration on Wednesday recommended healthcare facilities transition away from using Getinge's GETIb.ST heart devices as they continued to have safety and quality concerns. Reporting by Sriparna Roy in Bengaluru; Editing by Shailes
G

Adriatic Metals, Diageo, GB Group

EUROPE RESEARCH ROUNDUP-Adriatic Metals, Diageo, GB Group April 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adriatic Metals, Diageo and GB Group, on Tuesday. HIGHLIGHTS * Adriatic Metals Plc ADT1.L : Stifel raises target price to 275p from 250p * Diageo Plc DGE.L : Morgan Stanley cuts target price to 2400p from 2430p * GB Group Plc GBGP.L : Peel Hunt raises target price to 360p from 340p * H&M HMb.ST : Morgan Stanley raises
A
B
B
D
D
D
G
H
I
L
P
H
G

Getinge Sees FY 2024 Quality-Related Costs At About Half Of Costs In 2023

BRIEF-Getinge Sees FY 2024 Quality-Related Costs At About Half Of Costs In 2023 April 22 (Reuters) - Getinge AB GETIb.ST : GETINGE CEO: HEART BALLOON PUMP BACKLOG GRADUALLY REDUCING, BUT SIGNIFICANT BACKLOG STILL GETINGE CFO: FAIR ASSUMPTION THAT FY 2024 COSTS FOR QUALITY IMPROVEMENTS WOULD BE ABOUT HALF OF QUALITY-RELATED COSTS IN TO 2023 GETINGE
G

Medical gear maker Getinge beats profit expectations, shares jump

UPDATE 3-Medical gear maker Getinge beats profit expectations, shares jump Updates share reaction in paragraph 2, adds CEO, CFO comments in paragraphs 5, 9, 11 By Greta Rosen Fondahn and Elsa Ohlen April 22 (Reuters) - Medical equipment maker Getinge GETIb.ST reported a smaller than expected drop in first-quarter core profit on Monday, as new orders offset the costs of resolving prolonged problems with its product packaging and heart products.
G
J

Getinge Keeps 2024 Net Sales Outlook Unchanged

BRIEF-Getinge Keeps 2024 Net Sales Outlook Unchanged April 22 (Reuters) - Getinge AB GETIb.ST : ADJUSTED EBITA MARGIN DECLINED Y/Y AS RESULT OF CONTINUED COSTS FOR QUALITY IMPROVEMENTS IN BUSINESS AREA ACUTE CARE THERAPIES AND HIGHER COSTS FOR INPUT GOODS AND EMPLOYEES OUTLOOK REMAINS UNCHANGED FOR 2024: NET SALES EXPECTED TO INCREASE BY 2–5% ORG
G

Medical gear maker Getinge's Q1 core profit beats expectations

Medical gear maker Getinge's Q1 core profit beats expectations April 22 (Reuters) - Medical equipment maker Getinge GETIb.ST reported a smaller-than-expected drop in its first-quarter core profit on Monday, as new orders offset the costs of resolving prolonged problems with its product packaging and heart products. Reporting by Greta Rosen Fondahn
G

Getinge Gets EU MDR Approval Of Advanta V12 Covered Stent System

BRIEF-Getinge Gets EU MDR Approval Of Advanta V12 Covered Stent System April 11 (Reuters) - Getinge AB GETIb.ST : RECEIVES EU MDR APPROVAL OF ADVANTA V12 COVERED STENT SYSTEM Further company coverage: [GETIb.ST] (Gdansk Newsroom)
G



الشروط

الأصول الشائعة

إخلاء المسؤولية: تتيح كيانات XM Group خدمة تنفيذية فقط والدخول إلى منصة تداولنا عبر الإنترنت، مما يسمح للشخص بمشاهدة و/أو استخدام المحتوى المتاح على موقع الويب أو عن طريقه، وهذا المحتوى لا يراد به التغيير أو التوسع عن ذلك. يخضع هذا الدخول والاستخدام دائماً لما يلي: (1) الشروط والأحكام؛ (2) تحذيرات المخاطر؛ (3) إخلاء المسؤولية الكامل. لذلك يُقدم هذا المحتوى على أنه ليس أكثر من معلومات عامة. تحديداً، يرجى الانتباه إلى أن المحتوى المتاح على منصة تداولنا عبر الإنترنت ليس طلباً أو عرضاً لدخول أي معاملات في الأسواق المالية. التداول في أي سوق مالي به مخاطرة عالية برأس مالك.

جميع المواد المنشورة على منصة تداولنا مخصصة للأغراض التعليمية/المعلوماتية فقط ولا تحتوي - ولا ينبغي اعتبار أنها تحتوي - على نصائح أو توصيات مالية أو ضريبية أو تجارية، أو سجلاً لأسعار تداولنا، أو عرضاً أو طلباً لأي معاملة في أي صكوك مالية أو عروض ترويجية مالية لا داعي لها.

أي محتوى تابع للغير بالإضافة إلى المحتوى الذي أعدته XM، مثل الآراء، والأخبار، والأبحاث، والتحليلات والأسعار وغيرها من المعلومات أو روابط مواقع تابعة للغير وواردة في هذا الموقع تُقدم لك "كما هي"، كتعليق عام على السوق ولا تعتبر نصيحة استثمارية. يجب ألا يُفسر أي محتوى على أنه بحث استثماري، وأن تلاحظ وتقبل أن المحتوى غير مُعدٍ وفقاً للمتطلبات القانونية المصممة لتعزيز استقلالية البحث الاستثماري، وبالتالي، فهو بمثابة تواصل تسويقي بموجب القوانين واللوائح ذات الصلة. فضلاً تأكد من أنك قد قرأت وفهمت الإخطار بالبحوث الاستثمارية غير المستقلة والتحذير من مخاطر المعلومات السابقة، والذي يمكنك الاطلاع عليه هنا.

تحذير المخاطر: رأس مالك في خطر. المنتجات التي تستخدم الرافعة قد لا تكون مناسبة للجميع. يرجى الاطلاع على تنبيه المخاطر.